01.31.19
Essity’s net sales in 2018 increased 8.5% compared with the corresponding period a year ago to SEK 118.5 billion ($13 billion). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, increased 2.6%, of which volume accounted for 0.5% and price/mix for 2.1%. Organic net sales increased 0.9% in mature markets and increased 5.9% in emerging markets. Emerging markets accounted for 35% of net sales. Exchange rate effects increased net sales by 3.5%. Acquisitions increased net sales by 2.4%, of which the acquisition of BSN medical accounted for 1.8% and acquisitions relating to the increase in the shareholding in associates in Latin America accounted for 0.6%.
In the Personal Care segment, 2018 net sales increased 11.7% to SEK 45.3 billion ($5 billion). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, increased 3%, of which volume accounted for 2.4% and price/mix for 0.6%. Organic net sales in mature markets increased 2.3%. In emerging markets, which accounted for 36% of net sales, organic net sales increased 4.4%. Acquisitions increased net sales by 5.8%, of which the acquisition of BSN medical accounted for 4.8% and acquisitions relating to the increase in the shareholding in associates in Latin America accounted for 1%. Exchange rate effects increased net sales by 2.9%.
For Incontinence Products, organic net sales increased 4.2%. Growth was related to emerging markets, North America and Western Europe. For Baby Care, organic net sales decreased 2.3%. The decrease was related to emerging markets. Organic net sales increased in Western Europe. For Feminine Care, organic net sales increased 9.3%. The increase was related to both emerging markets and Western Europe.
In the fourth quarter of 2018, net sales increased 8.5% compared with the corresponding period a year ago to SEK 31.1 billion ($3.4 billion). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, increased 3.3%, of which volume accounted for 0.5% and price/mix for 2.8%. Higher prices in all business areas had a positive impact on organic net sales. The higher volumes were attributable to Personal Care.
Personal Care net sales in the fourth quarter increased 8.1% to SEK 11.7 billion ($1.3 billion). Organic net sales increased 3.1%, of which volume accounted for 2.1% and price/mix for 1.0%. Organic net sales in mature markets increased 1.9%. In emerging markets, which accounted for 36% of net sales, organic net sales increased 5.6%. Acquisitions relating to the increase in the shareholding in associates in Latin America increased net sales by 1.1%. Exchange rate effects increased net sales by 3.9%.
For Incontinence Products, organic net sales increased 4%. Growth was related to emerging markets, North America and Western Europe. Growth in Europe was attributable to both the retail trade and the healthcare sector. In North America, growth was attributable to the healthcare sector. For Medical Solutions, organic net sales decreased 0.9%, mainly related to the U.S. For Baby Care, organic net sales decreased 1.9% mainly related to emerging markets. For Feminine Care, organic net sales increased 13.4%. The increase was related to emerging markets and Western Europe.
In the Personal Care segment, 2018 net sales increased 11.7% to SEK 45.3 billion ($5 billion). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, increased 3%, of which volume accounted for 2.4% and price/mix for 0.6%. Organic net sales in mature markets increased 2.3%. In emerging markets, which accounted for 36% of net sales, organic net sales increased 4.4%. Acquisitions increased net sales by 5.8%, of which the acquisition of BSN medical accounted for 4.8% and acquisitions relating to the increase in the shareholding in associates in Latin America accounted for 1%. Exchange rate effects increased net sales by 2.9%.
For Incontinence Products, organic net sales increased 4.2%. Growth was related to emerging markets, North America and Western Europe. For Baby Care, organic net sales decreased 2.3%. The decrease was related to emerging markets. Organic net sales increased in Western Europe. For Feminine Care, organic net sales increased 9.3%. The increase was related to both emerging markets and Western Europe.
In the fourth quarter of 2018, net sales increased 8.5% compared with the corresponding period a year ago to SEK 31.1 billion ($3.4 billion). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, increased 3.3%, of which volume accounted for 0.5% and price/mix for 2.8%. Higher prices in all business areas had a positive impact on organic net sales. The higher volumes were attributable to Personal Care.
Personal Care net sales in the fourth quarter increased 8.1% to SEK 11.7 billion ($1.3 billion). Organic net sales increased 3.1%, of which volume accounted for 2.1% and price/mix for 1.0%. Organic net sales in mature markets increased 1.9%. In emerging markets, which accounted for 36% of net sales, organic net sales increased 5.6%. Acquisitions relating to the increase in the shareholding in associates in Latin America increased net sales by 1.1%. Exchange rate effects increased net sales by 3.9%.
For Incontinence Products, organic net sales increased 4%. Growth was related to emerging markets, North America and Western Europe. Growth in Europe was attributable to both the retail trade and the healthcare sector. In North America, growth was attributable to the healthcare sector. For Medical Solutions, organic net sales decreased 0.9%, mainly related to the U.S. For Baby Care, organic net sales decreased 1.9% mainly related to emerging markets. For Feminine Care, organic net sales increased 13.4%. The increase was related to emerging markets and Western Europe.
